From: Topical gel based nanoparticles for the controlled release of oleanolic acid: design and in vivo characterization of a cubic liquid crystalline anti-inflammatory drug
S.No.
Ingredients
OA-LCNPG1(w/w)
OA-LCNPG2(w/w)
OA-LCNPG3(w/w)
NG(w/w)
1
CP 934
1.5%
1.0%
0.5%
2
HPMC K4M
3
glycerol
10%
4
propylene glycol
5%
5
Triethanaolamine
2%
7
Azone
1%